Empowering Health WITH INNOVATION
ZEPYA LABORATORIES
Zépya Laboratories, founded in Switzerland, has established itself as a leader in the development of groundbreaking medications for weight management and diabetes control. With years of research, clinical trials, and scientific exploration, Zépya is committed to improving global health by providing safe, effective, and scientifically proven treatments.
Our flagship products, Tirzepatide and Retrotatide, represent the culmination of years of research and dedication to finding solutions that significantly enhance quality of life for individuals struggling with obesity and diabetes. At Zépya, we believe in the transformative power of innovation in healthcare, and we strive to be at the forefront of developing advanced medications that offer real solutions for real people.
Our Experience in the Field
Our RESEARCH TEAM
Dr. Sarah Miller – Lead Research Scientist
Dr. Miller heads our research division, focusing on the development of novel peptides for metabolic diseases. With over 15 years of experience in endocrinology and diabetes treatment, she has led numerous clinical trials and contributed to the development of Zépya’s key medications.
Dr. James Roberts – Clinical Research Specialist
Dr. Roberts brings his expertise in clinical pharmacology to our team, overseeing all clinical trial phases for our products. His passion for translating scientific research into practical solutions ensures that every product Zépya develops is safe, effective, and beneficial to patients worldwide.
Dr. Helen Schwartz – Director of Medical Affairs
Dr. Schwartz is responsible for the strategic direction of Zépya’s medical research and partnerships. Her extensive background in regulatory affairs and medical science has been vital in guiding our products through the approval processes of global health authorities.